Replies to post #11517 on US Stem Cell Inc (USRM)

[andyshow]

Agree.
Excellent post.
Excellent read.

[Dragon Lady]

"Investing in Bioheart, Inc. (ERRORS and QUESTIONS??) $$$$$MUSTREAD$$$$

RegMed companies are in fact the paradigm shift in healthcare and will literally reshape mankind as we know it by extending lives beyond 140 years of age. (There is NO PROOF that "regmed" or any other technology at this point in time is "extending" anyone's life span to 140 yrs, none. It's never happened.)
The Stem Cell investment sector is still under the radar as the digital age was in 1993. Before the World Wide Web saturated our world, YHOO traded at $0.43 a share in 1996 and three years later it traded at $105.00 a share. (WRONG, Yahoo NEVER traded as a penny stock, ever. It went public at $33 DOLLARS a share, peaking on IPO day at $43 DOLLARS a share, and has NEVER traded anywhere near being a penny or microcap stock, ever. Yahoo/s lowest historical share price was about $8.50 a share in 2001 w/ a market cap of about $8 BILLION then)
Ask yourself how much a company is worth that can heal a broken heart? $90 Billion? $500 Billion? A Trillion Dollars or more? (A TRILLION OR MORE? No company in U.S. HISTORY has yet to crack the $TRILLION dollar market cap- not Exxon-Mobile, not Google who's close, not Apple one of the most profitable and cash rich companies in world business history, not Microsoft, Not GE, NO ONE. Only 15 economies in the world had gross domestic product exceeding $1 trillion in 2012. . PURE FANTASY)
(companies heal broken hearts every minute of every day - heart surgery, stents, by-passes, etc. It's not new. There's no stem cell company ever proven to "heal" a "broken heart", it does not exist in any proven, trial completed safe, regulated form yet in the U.S.)

How much would you pay for a treatment that will regenerate your damaged heart and allow you to breath air for another 30 years of life? (There's no company yet to prove that they can "regenerate" a damaged heart and cause a person to breath air for another 30 years of life? NO WHERE, never has been proven or is in existence at this point in time. Pure fantasy. No major regulatory body such as the FDA says it exists, no medical insurance company recognizes and pays for it as a "treatment", etc) Stem Cell science is the medical technology that is here today and not just in a Star Trek movie that takes place in 2456. (Star Trek was a 100% made up, fantasy TV show- what does it have to do with anything? One's trying to claim that this stem cell, 1.5 cent stock is 400 plus yrs off into the future, operating out of a tiny, rented suite in Florida? Really?) Tens of thousands travel off-shore from the USA every year to secure these stem cell treatments due to the FDA being hooked on a platform of synthetic drugs and protocols established in the 1950’s. (Where is the documented proof that TENS OF THOUSANDS "travel off shore" for supposed "stem cell" so called "treatments"? What journal or govt research body or similar has documented this to be true? Where?) In the next 24 months (not 18 months, or 26 months or 47 months? How is it known this will occur in 24 months? What research, documentation shows this to be true and proven?) this will all change forever as Bioheart and other RegMed companies break through and achieve FDA validation of cellular treatments using our own cells to treat disease. Big Pharma will be turned upside on their cumulative heads and will be forced to pay hundreds of billions of dollars for this technology. (Who's "big pharma" and what proof is there they're gonna pay "hundreds of billions of dollars" for what "technology"? Where? Where and what is this mystery "technology" that does not exist yet today?)

Like the DotCom boom, NEXT BIG THING is Regenerative Medicine, are you ready?

Putting it all together – Bioheart, Inc. (OTCMKTS:BHRT) Is now the time for investment? Lets discuss the reasoning why your receiving this email. (what email, I didn't get an email??) On October 24, 2014 16:00 ET, after market close, a promising but financially restricted microcap (what's a "financially restricted microcap, what does that mean?)announced that it had closed on a $3,000.000.00 financing commitment from Magna LLC. ( www.magnallc.com ) That Company is Bioheart, Inc. (OTCMKTS:BHRT) Please review the SEC filing and take note that Magna is not receiving an extraordinary discount, only 7%! For those that follow stocks this discount means Magna feels strongly about the upside of Bioheart share appreciation.
(Magna, just prior to the "credit line" did a convertible, aka toxic note for a payment value of about $200K cash to BHRT, but BHRT may owe as much as $300K to Magna. It's at 12% interest and has a 55% discount on the shares, 1 CENT shares essentially. This is not new. Also, for the "credit line" BHRT is going to pay a minimum of about 9 MILLION share of dilution, as high as 15 MILLION shares just for the upfront fees to Magna. BHRT has had similar "credit lines" in the recent past- the Greystone line that just ended earlier this yr, a 24 month, "draw down" line for $1 million over 24 months, nothing "new" here)

http://www.sec.gov/Archives/edgar/data/1388319/000114544314001254/e61149_8k.htm

Picking the right time to invest is predicated upon spotting milestones that have surfaced in the past with other companies and being able to match those events with other public companies before the market puts 2 + 2 = INVESTMENT. (Basic math says that 2 + 2 = 4. I'm not aware of any new discoveries that have ever altered that fact?) Buying stock in break-out companies is similar to musical chairs we played as children, the less chairs available the more demand and furry to secure chairs/stock. (I've never seen or read a single expert commentary on investing from academia, govt such as the SEC or any source that says it's akin to kids playing musical chairs. This must be some newly invented theory? Any research backing it up?) This is why when thinly traded companies achieve awareness the share price explodes.

HISTORY DOES REPEAT ITSELF! Nuvilex, Inc.(OTCMKTS:NVLX) was Bioheart Inc so to speak in every way except in name in 12/2012 until it closed and received its first installment of a $3,500.000.00 share purchase agreement. Nuvilex was trading around $0.02 a share, it had an outstanding share balance of 552,000,000 shares and two months after the late December-2012 8K filing NVLX would go from $0.02 to a high of $0.59 a share 60 days after 1st receiving the initial installment! So why does this happen? Why do microcaps explode in value? (why do most, as in 95% or more of penny microcaps end in BK, bankruptcy? Those are the published facts from academia, the SEC and similar sources? Most microcaps only "explode" in the sense that they fail and go out of business entirely?) Here is some insight…. Right now BHRT is trading at a valuation of $9,000,000.00, (actually, as of close of market on Friday, BHRT has a market cap of $8.28 million) yet Bioheart’s sector rivals with similar clinical research and assets trade upwards of $80,000,000.00 on the low end in valuation. Please note that NVLX is trading over $179.64M valuation. Bioheart does not have free cash flow as these other companies do which would allow Bioheart to engage with investor relations companies. (what "investor relations companies"? What do "investor relations companies" have to do with creating successful, FDA approved products that get approved and then go to market, generate sales and thus profits? NEVER have heard of this business model before- that "investor relations companies" make large, profitable, successful companies? I know Microsoft before going public never used an "investor relations" company that I'm aware of? They just made great products that sold at high profit margins and produced profits and wealth? Who are these companies- any names available?) These I/R companies promote company stocks non-stop on social media as well as email campaigns, paid article submissions and numerous other channels of awareness. These I/R-services cost $40,000.00 per month on the low side and upwards of $100,000.00 or more! (Again, ANY NAMES and fee schedules of these companies and proof they charge supposedly $40 to $100K a month, name one or two? A single published market research paper or some credible source?) Based upon the financials

Bioheart has been dependent upon Broker-Dealers often referred to as “hard-money” to fulfill its monthly cash-burn requirements for several years also personal investment of its Insider-Mgt. which we will discuss further below. (What "broker-dealers" has BHRT been "dependent on? Who? BHRT has used lenders/investors, well known names on Wall St (Asher, Grey Stone, Daniel James) who provide convertible debt and other cash-for-share deals to companies in poor financial condition and thus high risk categories. This is nothing new. It's common practice and they're not known as "broker-dealers" they are known as lenders and financiers.) These brokers receive conversion discounts of 40-60% off the share price and as such have little or no reason to “Promote” (why should a lender/bank/finance company "promote" a company they lend to? That's not the business they're in? What bank "promotes" companies they lend money to? Specific examples would be great.) the company so as to ensure the BD’s are spending the least to garner the highest returns. If you have read Magnum’s share purchase agreement you will notice that Bioheart is only giving Magnum a 7% discount when it buys BHRT-common stock of which Magnum will take and sell into the open market. Why does this matter to you? Think about it, Magnum could never stay in business on a 7% margin of return in the micro-cap world.
(well for one thing, Magna is getting a $150K upfront fee (says in the 8-K as at least 9 MILLION shares of stock) plus another $25K in legal fees on the front-end. They have a lot more ways they make their money than just a share discount. They are not "stock promoters", they're lenders and a finance house)

To that end, Magnum will undoubtedly either hire its own Investor Services to promote Bioheart or Bioheart will do so internally? Either way this is a HUGE win for investors that buy in early before the inevitable upcoming spike valuation! More than Just the $$$’s –
(what proof is there that Magna (not MAGNUM) does stock promoting - that's probably illegal if they're acting as a lender and taking common stock, free trading shares of stock in return for cash? Not sure how that would work?)

Investing in the People- If you viewed only the Executive Management – Board of Directors at Bioheart you could easily assume you were reviewing the credentials of a Fortune 500 Company and not a microcap stock. (Really? I never got that impression? They have very avg credentials- educations, school names average at best, very little to no med/pharma FDA regulated company experience outside of BHRT, no FDA regulatory or pharma FDA regulated-product-to-market approval and success for the CEO and CSO that I'm aware of, nothing spectacular in my book, IMO?) You can review the Insiders here- http://www.bioheartinc.com/ please contemplate the questions I have asked below. How does a microcap such as Bioheart attract a Chairman of the Board of Dr. William P. Murphy Jr. caliber? http://en.wikipedia.org/wiki/William_P._Murphy_Jr. Dr. Murphy is responsible for inventions that are common place now in life sciences. His work has reshaped health care time and again over the past 7 decades. He is responsible for saving the lives of millions through creation of standard of care devices, including the first physiologic cardiac pacemaker – the widely used hollow fiber artificial kidney, the first disposable medical procedural trays, the first motor-driven angiographic injectors, first disposable catheters, and the modern blood transfusion bags to name just a few of his inventions and developments over the past 70 years.

So again, ask yourself, why has Dr. Murphy at the twilight of his life placed his exceptional good-name on a microcap biotech and invested several million dollars of his own personal fortune?

Why does Mike Tomas the CEO take all compensation in BHRT common stock? Does he see a future with a world where Bioheart’s cellular delivery products are 1st in class? http://www.bioheartinc.com/AboutUs/Management/MikeTom%c3%a1s
(there's NO PROOF that Tomas takes all compensation in common stock? Where? SEC filing and page numbers would be great. Latest 10-Q filing shows he gets and takes a cash base salary of $525K and is now to also get a $500K CASH bonus? Where does a 10-Q or similar say otherwise?)


How does Bioheart retain a renowned (renowned? She's not even an M.D. or Ph.D.? How many journal publications does she have under her own name? Not much that I'm aware of? Almost her entire career experience has been spent at Bioheart, she holds a B.S. and a masters in Chem. No Ph.D. even) Chief Science Officer like Kristin Comella? http://www.bioheartinc.com/AboutUs/Management/KristinComella

I am of the opinion that these incredible individuals have spied the future, a world where healthcare no longer comes from synthetic drugs. The personal and financial commitment by the insiders is a clear indication they feel strongly that Bioheart, Inc. (OTC-BHRT) stands poised to fundamentally transform treatment to those battling acute heart failure. I see the potential based upon previous instances of other companies in the RegMed sector for a possible drastic market cap valuation increase in value in BHRT in the coming months. (then why is the stock at 1.6 cents right now and at an $8.35 million market cap, cash poor and just did a toxic, convertible note deal w/ Magna, with a 55% share discount and 12% interest rate for about $200K in survival cash? Why is no high-end, venture capital firm, major pharma or bio-med partner or large, non dilutive investor stepping in to finance this supposed world class and apparently "miracle", supposed world changing group and technology? Why? The markets are swimming in investment cash right now from the bull market boom- one of the best times in history. Why only dilution financing and tiny amounts trickling in, on an on-going basis at that? It's takes $10's and $10's of millions to conduct even a single phase II/III FDA quality/level trial, BHRT does not and will not after the Magna credit line have anywhere near that cash/money, let alone be able to pay off their high debt levels? Why?) As always these are my opinions. Before investing please consult a licensed investment professional and consider all risks before investing.

Bioheart’s Corporate Health > Ticker Symbol of Bioheart, Inc. is BHRT Last trade $0.016 > Current liabilities down $3.6 million (27%) from beginning of year. Down 49% in 24 months from high of $13.6m (NO, it's not down 49%, the present debt is above $9 MILLION, which is not 49% of $13 million)> Working capital deficit improved by 28% from beginning of year > Revenue up by 2,369% comparing 2nd quarter 2014 to 2nd quarter 2013 > Revenue up by 3,670% comparing YTD 2014 to YTD 2013 > Net loss down 39.8% comparing 2nd quarter 2014 to 2nd quarter 2013 > Generated over $1m in revenues so far this year (NO, latest 10-Q shows about $800K in revenues with a cost of sales of about $200K for around $600K revenues after costs)-from $0 last year as compared to net loss of $1,269,231 YTD 2013 > Cash used in operating activities of $507K in YTD 2014 as compared to $1,095K in YTD 2013 (the cash use decline is primarily because R&D spending has gone to near ZERO and also some reduction in interest payments, that came at a huge cost of dilution to eliminate those past debts, 10's of millions of shares of dilution. The instant any actual, realistic R&D for "trials" were to take place, that cash use number will jump tremendously, it's been cut down by $300K just near term as they axed trial and actual "heart research" spending to less than $5K per month); down by 54% > Eliminated development stage reporting, no longer inception to date statements of operations or cash flows > At the next 10K the removal of “Going Concern Classification” will be removed (HOW can a amateur blogger, w/o help of illegal insider trading or other similar information know that the auditor's "going concern" is going to be removed, in a set of financials that does not exist yet, and won't exist for at least 3 more months, let alone undergo professional audit by a licensed CPA firm until then? How is that possible?)> Revenue creation; Just this year, opened clinics or signed partnerships with healthcare organizations in Australia (what PR or SEC documents shows them operating in Austrialia? Reference or link would be great), Honduras, South Africa, Colombia, Turkey, Azerbaijan and 2 new cities in Mexico > Initiated trials in several new indications including dry macular degeneration and erectile dysfunction > Completed ANGEL trial and 3, 6 and 12 month results overwhelmingly positive"

End of blog.

My own 2 cent opinions of course and questions about this blog, accuracy and validity of its statements and its claims. Do one's own due diligence as the above blog states. Always.

[Dragon Lady]

YAHOO was never, ever, ever a penny stock or traded for .43 cents or on the OTC. NEVER. One can't look at a chart w/o an understanding of how STOCK SPLITS WORK. The past price on a long term chart, for a company that has split many times, because it APPRECIATED RAPIDLY and INCREASED MASSIVELY IN MARKET cap, makes the past chart price appear lower. Not how it works.

Yahoo has always been a "listed" stock and only traded on the NASDAQ. Period. End of story.

http://news.cnet.com/2100-1033-209413.html

http://en.wikipedia.org/wiki/Timeline_of_Yahoo!

"April 12, 1996: Yahoo! has Initial public offering, closing at US$33.00—up 270 percent from the IPO price—after peaking at US$43.00 for the day.[2][4]"

http://online.wsj.com/article/0,,SB849504268462964500,00.html

From the WALL STREET JOURNAL, 1996:
"By JOAN E. RIGDON | Staff Reporter of THE WALL STREET JOURNAL
Yahoo! Inc.'s initial public offering scored an impressive 154% gain. But if history -- and business fundamentals -- are any guide, its stock may rapidly cool.

The highly touted Internet search service had priced its shares at $13 each on Thursday. Friday, it opened on the Nasdaq Stock Market at $24.50 a share and roared to $43 before retreating somewhat and closing at $33.

When it was over, the company that was just a graduate-school project a little more than a year ago had a market capitalization of $848 million, about one-third of the market cap of technology giant Silicon Graphics Inc.

Yahoo, founded in March 1995, had revenue of $1.4 million for the nine months ended Dec. 31. It had a loss of $634,000, or three cents a share, for the period.

In IPO history, Yahoo's first-day run stands behind only the rocket rides of Secure Computing Corp. last year (up 247%) andHome Shopping Network Inc. a decade ago(165%), according to Securities Data Co. of Newark, N.J. The previous No. 3 was Boston Chicken Inc., which surged 142% when it went public in 1993. Evenlast year's seemingly stratospheric Netscape Communications Corp. IPO was tepid by comparison, rising only 108% its first day out."

GOOGLE, an amazing tool to find FACTS.

[Dragon Lady]

"Investing in Bioheart, Inc. $$$$$MUSTREAD$$$$ "

The "investorstem" "blog" STATED:
"Current liabilities down $3.6 million (27%) from beginning of year. Down 49% in 24 months from high of $13.6m "

CEO BLOG, Mike Tomas of BHRT just stated:

"Current liabilities were reduced 23% from $13.4m to $10.3m YTD. This was accomplished by debt to equity conversion at $0.04 as well as debt limitations under Florida law."

Looks like CEO is stating that the total reduction from $13.4m to $10.3m is 23% (TWENTY THREE PERCENT), NOT 49%. (also the high number according to the CEO is $13.4 mil, not $13.6 million)

NOT the "49% in 24 months from high of $13.6m" as was stated many places here prior to this CEO blog.

I guess the CEO and his "blog" is the CORRECT ONE HERE? That's a pretty huge difference in percentages stated? One of those statements must be in gross error? Like about a 50% ERROR. 49% versus 23%, actually a tad more than a 50% ERROR.

I would have to assume, IMHO, that the company CEO would be correct?

[k124Inv]

This, hands down is probably the best post I've ever read. I'm already in BHRT, but if I wasn't... this would have convinced me in about 3 minutes